Parsatuzumab (Synonyms: Anti-EGFL7; RG 7414) |
| Catalog No.GC69662 |
Parsatuzumab (Anti-EGFL7; RG 7414) es un anticuerpo monoclonal humanizado que se une a EGFL7 como modulador inmunológico. Parsatuzumab bloquea selectivamente la interacción entre EGFL7 y las células endoteliales, lo que puede inhibir la angiogénesis y reducir la supresión del factor de crecimiento endotelial vascular (VEGF).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1312797-14-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Parsatuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Parsatuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *